Chinese Academy Of Sciences;Shanghai Institutes For Biological Sciences
发明人:
SHI, Yufang,WANG, Ying,DU, Liming,LIN, Liangyu
申请号：
EP17876571
公开号：
EP3549598A4
申请日:
2017.11.28
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Provided is the use of an insulin-like growth factor-2 for preparing a pharmaceutical composition, wherein the pharmaceutical composition is used for (i) promoting the expression of the macrophage PD-L1, and/or (ii) inhibiting the expression of the macrophage IL-1β. Also provided is a pharmaceutical composition containing insulin-like growth factor-2 as an active ingredient.
